March 09, 2026

​​​​​​​PsA Treatment Options Expand

Phase 3 POETYK trial results support FDA approval of deucravacitinib for adults with active PsA.

Conexiant

March 06, 2026

RA-ILD: Tracking Function and CT

Conventional monitoring markers do not change before deaths in this predominantly mild cohort.

Conexiant

March 05, 2026

Anti-CD146 Linked to Silica in Systemic Sclerosis

Comparative analysis across exposed workers, cancer controls, and healthy donors supports specificity.

Conexiant

March 04, 2026

Exercise in Osteoarthritis: Does It Help?

Overview data on exercise therapy in osteoarthritis question its universal promotion

Conexiant

February 25, 2026

Upadacitinib and Pain in RA, PsA

Mediation analysis suggests direct and indirect effects on pain reduction in rheumatoid and psoriatic arthritis.

Conexiant

February 24, 2026

Can CT Radiomics Detect Osteoporosis?

Radiomics analysis of lumbar spine computed tomography is compared with established imaging-based measures of bone density.

Conexiant

February 23, 2026

Sleep Disruption and Osteoarthritis Risk

Investigators find that short sleep, insomnia, and night shift work are associated with increased risk of knee and hip osteoarthritis and joint replacement.

Conexiant

February 18, 2026

Combo Therapy for Psoriasis With Obesity

A phase 3b trial tests ixekizumab plus tirzepatide in adults with moderate-to-severe plaque psoriasis and obesity or overweight.

Conexiant

February 17, 2026

Corneal Imaging and an ‘Overlooked Source’

Investigators evaluate how iris pigmentation influences Scheimpflug-derived corneal densitometry measurements.

Conexiant

February 16, 2026

Shoulder MRI: Rethinking Findings

Routine imaging may detect age-related tendon changes that do not explain patient-reported shoulder pain.

Conexiant